Tinnitus: What Could Be Causing It and What to Do Next

What Is Tinnitus and How Common Is It?

Tinnitus is the perception of ringing, buzzing, hissing, clicking, or roaring in one or both ears without any corresponding external sound. It is not a disease by itself; it is a symptom generated somewhere along the auditory pathway, from the outer ear canal to the auditory cortex.

Population data are consistent. A 2013 systematic review in PLOS ONE (N = 60 studies) estimated global prevalence at 14.5% of adults, with chronic tinnitus affecting approximately 2.5% of the general population severely enough to impair quality of life (1). In the United States, the CDC estimates that approximately 50 million adults experience some form of tinnitus (2).

Subjective vs. Objective Tinnitus

The distinction matters clinically. Subjective tinnitus, heard only by the patient, accounts for more than 99% of cases. Objective tinnitus can actually be heard by an examiner with a stethoscope held near the ear canal. Objective tinnitus is rare and almost always has a vascular or mechanical cause.

Acute vs. Chronic

Tinnitus lasting fewer than 3 months is classified as acute. A 2006 prospective study in Archives of Otolaryngology found that approximately 50% of patients with new-onset tinnitus reported spontaneous improvement within 3 months (3). Chronic tinnitus, persisting beyond 3 months, is considerably less likely to resolve without targeted management.

The Most Common Causes of Tinnitus

Noise-induced cochlear hair-cell damage is the single most frequent underlying mechanism. After that, causes range from cerumen impaction to life-threatening vascular lesions. A structured differential is the only way to avoid missing the 5% of cases that require urgent intervention.

Noise-Induced and Age-Related Hearing Loss

Sensorineural hearing loss (SNHL) from noise exposure or presbycusis is responsible for an estimated 60 to 70% of all tinnitus cases. Damage to outer hair cells in the basal cochlea reduces afferent input, which the central auditory system compensates for by increasing spontaneous neural firing. That increased firing is perceived as sound.

The National Institute on Deafness and Other Communication Disorders (NIDCD) reports that approximately 17% of Americans aged 45 to 64 have some degree of hearing loss, rising to 33% of adults over 65 (4). Each 5 dB increment in hearing threshold loss correlates with a measurable increase in tinnitus severity on validated scales (5).

Ototoxic Medications

More than 200 drugs are recognized as ototoxic. The major classes include:

• Aminoglycoside antibiotics (gentamicin, tobramycin): damage cochlear hair cells irreversibly through reactive oxygen species generation (6).
• Loop diuretics (furosemide, ethacrynic acid): disrupt the endocochlear potential by inhibiting ion transport in the stria vascularis.
• Platinum-based chemotherapy (cisplatin, carboplatin): cisplatin-induced ototoxicity occurs in 40 to 80% of treated patients according to a meta-analysis published in Journal of Clinical Oncology (7).
• High-dose salicylates: aspirin at doses exceeding 3 g per day typically causes reversible tinnitus; at lower doses the risk is substantially smaller (8).
• Quinine and antimalarials: produce reversible tinnitus at therapeutic doses in a dose-dependent fashion.

Always review the full medication list before attributing tinnitus to an unknown cause. Stopping or substituting the offending agent often resolves symptoms within days to weeks.

Ear Canal and Middle Ear Disease

Physical blockage or mechanical disruption of the conductive pathway generates tinnitus by altering resonance and reflection of bone-conducted sound.

Cerumen impaction is the simplest correctable cause. Complete occlusion of the external auditory canal is sufficient to produce low-frequency tinnitus and conductive hearing loss, both of which typically resolve immediately after irrigation or microsuction.

Otitis media with effusion creates a similar conductive mechanism. Tympanometry showing type B (flat) curves with absent reflexes confirms middle ear fluid. A 2017 Cochrane review (14 trials, N = 1,736 children) found that ventilation tube insertion resolved conductive hearing loss in the short term but noted limited long-term data on tinnitus specifically (9).

Otosclerosis causes progressive stapes fixation. Tinnitus is present in roughly 75% of otosclerosis patients at diagnosis, usually low-pitched and bilateral (10).

Meniere's Disease

Meniere's disease is defined by the triad of episodic vertigo, fluctuating low-frequency sensorineural hearing loss, and aural fullness with tinnitus. The underlying pathology is endolymphatic hydrops, an accumulation of endolymph that distends the membranous labyrinth.

The 2020 Barany Society classification criteria require at least two spontaneous vertigo episodes of 20 minutes to 12 hours, audiometrically documented low- to mid-frequency SNHL, and tinnitus or aural fullness, all in the absence of a better explanation (11). Tinnitus in Meniere's is characteristically low-pitched, fluctuates with attacks, and may become permanent in late-stage disease.

Pulsatile Tinnitus: Vascular Causes

Pulsatile tinnitus, a rhythmic sound synchronous with the heartbeat, demands a different workup from non-pulsatile tinnitus. The differential includes:

• Arteriovenous malformations (AVM) and dural arteriovenous fistulas: produce pulsatile tinnitus through turbulent flow. Gadolinium-enhanced MRI and MR angiography are first-line imaging.
• Carotid artery stenosis or dissection: stenosis above 50% can generate bruits audible to the patient.
• Sigmoid sinus diverticulum and dehiscence: an increasingly recognized cause of unilateral pulsatile tinnitus, often visible on CT of the temporal bones with contrast (12).
• Benign intracranial hypertension (pseudotumor cerebri): affects predominantly obese women of childbearing age; associated with pulsatile tinnitus, headache, and papilledema.
• Glomus tympanicum or jugulare tumors: vascular paragangliomas visible behind the tympanic membrane as a red mass; best imaged with CT and MRI of the temporal bone.

Any patient with pulsatile tinnitus should be referred for imaging. Missing a dural arteriovenous fistula carries a risk of intracranial hemorrhage.

Acoustic Neuroma (Vestibular Schwannoma)

Vestibular schwannoma is the diagnosis that must not be missed in unilateral tinnitus. These benign tumors of the eighth cranial nerve affect roughly 1 in 100,000 adults per year. Unilateral, high-pitched tinnitus combined with asymmetric SNHL and speech discrimination loss disproportionate to pure-tone thresholds is the classic presentation.

The AAO-HNS 2012 Clinical Practice Guideline on vestibular schwannoma recommends gadolinium-enhanced MRI as the diagnostic standard (13). A 2020 population-based study from Denmark (N = 4,861) found that unilateral tinnitus was associated with a 30-fold higher rate of subsequent vestibular schwannoma diagnosis compared to bilateral tinnitus (14).

Temporomandibular Joint (TMJ) Dysfunction

The temporomandibular joint shares ligamentous and muscular connections with structures adjacent to the middle ear. TMJ dysfunction produces somatic tinnitus, a subtype modifiable by jaw movement, dental clenching, or neck rotation.

A systematic review in JAMA Otolaryngology (2016, 14 studies) reported that 36% of tinnitus patients screened positive for TMJ dysfunction, compared to 18% in control populations (15). Referral to an oral and maxillofacial specialist or prosthodontist is appropriate when patients report that jaw movement worsens or temporarily relieves tinnitus.

Systemic and Metabolic Contributors

Several systemic conditions alter cochlear perfusion or auditory nerve function:

• Hypertension and cardiovascular disease: reduce cochlear blood flow. A cross-sectional analysis of 14,178 adults in the National Health and Nutrition Examination Survey (NHANES) found a significant association between hypertension and tinnitus (OR 1.31, 95% CI 1.12 to 1.53) (16).
• Diabetes mellitus: peripheral neuropathy can affect the auditory nerve; the ACCORD trial cohort showed higher rates of self-reported hearing difficulty in participants with poor glycemic control (17).
• Hypothyroidism: may cause low-frequency tinnitus through altered fluid homeostasis and reduced cochlear perfusion; thyroid replacement typically improves symptoms.
• Anemia: severe anemia increases cardiac output and turbulent flow, which may generate or worsen tinnitus.
• Autoimmune inner ear disease (AIED): rapid bilateral progressive SNHL with tinnitus, often responsive to corticosteroids.

Red Flags That Require Urgent Evaluation

Not all tinnitus is benign. Refer promptly when any of the following are present.

| Red Flag | Likely Concern | Next Step | |---|---|---| | Unilateral tinnitus + asymmetric SNHL | Vestibular schwannoma | Gadolinium MRI internal auditory canals | | Pulsatile tinnitus | Vascular lesion, AVM, paraganglioma | CT/MRI angiography temporal bones | | Tinnitus + sudden hearing loss (<72 hours onset) | Cochlear ischemia, viral labyrinthitis | Same-day ENT, consider IV corticosteroids | | Tinnitus + headache + papilledema | Idiopathic intracranial hypertension | Neuro-ophthalmology, LP opening pressure | | Tinnitus + facial nerve palsy | Ramsay Hunt syndrome, cholesteatoma | Urgent ENT | | Tinnitus following head trauma | Perilymph fistula, temporal bone fracture | CT temporal bones |

The AAO-HNS 2014 Clinical Practice Guideline on tinnitus explicitly states: "Clinicians should obtain an audiological examination in patients with tinnitus that is persistent (lasting 6 months or longer), unilateral, or associated with hearing loss." (18)

How Is Tinnitus Diagnosed?

Diagnosis is primarily clinical, supported by audiometric testing and, where indicated, imaging.

Initial Assessment

A thorough history identifies onset, character (ringing, buzzing, pulsatile, clicking), laterality, associated hearing loss, vertigo, otalgia, and medication use. Physical examination includes otoscopy, pneumatic otoscopy, and auscultation over the mastoid and neck for objective bruits.

The Tinnitus Handicap Inventory (THI), a validated 25-item questionnaire, grades tinnitus severity from mild (THI 0 to 16) to catastrophic (THI 78 to 100) (19). Baseline THI scoring guides treatment intensity and tracks response over time.

Audiometric Testing

Pure-tone audiometry identifies degree and configuration of hearing loss. Speech audiometry detects disproportionate word recognition scores that suggest retrocochlear pathology. Tympanometry and acoustic reflex testing evaluate middle ear function.

Otoacoustic emissions (OAEs) test outer hair cell integrity non-invasively; absent OAEs with normal tympanometry suggest cochlear rather than conductive pathology.

Imaging

Gadolinium-enhanced MRI of the internal auditory canals remains the gold standard for excluding vestibular schwannoma. CT of the temporal bones with contrast is preferred for bony detail when otosclerosis, cholesteatoma, or sigmoid sinus abnormalities are suspected.

Evidence-Based Treatments for Tinnitus

No single treatment eliminates tinnitus in all patients, but several interventions have meaningful evidence for reducing distress and improving function.

Cognitive Behavioral Therapy

CBT is the most evidence-supported psychological intervention for chronic tinnitus. A 2018 Cochrane review (28 randomized trials, N = 2,733) found that CBT produced a statistically significant reduction in tinnitus-related distress (standardized mean difference -0.56, 95% CI -0.82 to -0.30) and depression scores, though it did not reduce the loudness of tinnitus itself (20). The AAO-HNS guideline gives CBT a strong recommendation for patients with persistent, bothersome tinnitus (18).

Sound Therapy and Hearing Aids

For patients with concomitant hearing loss, properly fitted hearing aids reduce tinnitus perception by amplifying ambient sound and reducing auditory gain compensation. A 2017 meta-analysis in Ear and Hearing (N = 440 across 7 trials) found that hearing aid use produced a 22% reduction in THI scores on average (21).

Sound maskers and tinnitus masking features built into hearing aids reduce awareness of tinnitus during waking hours, though they do not modify the underlying neural process.

Tinnitus Retraining Therapy

Tinnitus Retraining Therapy (TRT) combines directive counseling with broadband sound generators to promote habituation. A randomized controlled trial by Henry et al. (N = 123) found TRT superior to standard masking therapy on THI scores at 18-month follow-up (mean THI reduction 28 vs. 18 points) (22).

Pharmacological Approaches

No drug is FDA-approved specifically for tinnitus. Benzodiazepines and tricyclic antidepressants are sometimes prescribed off-label but carry significant side-effect burdens without compelling efficacy data.

A 2022 systematic review in JAMA Otolaryngology evaluated 34 drug trials for tinnitus and concluded: "No pharmacological agent demonstrated consistent, clinically meaningful improvement in primary tinnitus outcomes across replication studies; routine drug therapy cannot currently be recommended." (23)

Intratympanic dexamethasone shows promise in sudden sensorineural hearing loss with tinnitus when given within 72 hours; this is a distinct indication from chronic idiopathic tinnitus.

Addressing Reversible Causes

When a reversible cause is identified, treating it is always the first step. Removing impacted cerumen, switching an ototoxic drug, treating otitis media, or correcting hypothyroidism may produce complete resolution. Hypertension control reduces cochlear ischemia risk. TMJ stabilization with an occlusal splint may reduce somatic tinnitus.

When to See a Specialist

Most primary care providers can manage straightforward bilateral tinnitus with symmetrical hearing loss in the context of noise exposure or aging. The following warrant specialist referral:

• Unilateral tinnitus of any duration.
• Pulsatile tinnitus.
• Tinnitus with sudden or rapidly progressive hearing loss.
• THI score above 58 (severe category), indicating significant psychological burden.
• Tinnitus unresponsive to 3 months of conservative management.

Otolaryngology (ENT) handles the diagnostic workup and surgical causes. Audiology manages rehabilitation and sound therapy. Neuropsychology or CBT-trained psychologists address the cognitive and emotional burden. Vascular surgery or neurointerventional radiology is involved when vascular lesions are confirmed.